RxDoctor Payments Data

Jason McHenry

Physician Assistant · Broken Bow, OKNPI 1881695948

Payments from drug & device makers

$372in general payments, 2019–2025

Across 24 payments — averaging $15.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$105
  • Boehringer Ingelheim$46
  • Novo Nordisk$37
  • Novartis$33
  • Lilly USA, LLC$28
  • Biohaven Pharmaceutical Holding Company Ltd.$26
  • plus $97 from 5 others

What the payments were for

  • Food & beverage$372100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$372 in reported general payments places this provider in the 55th percentile of 1,491 physician assistant providers in Oklahoma.

See all physician assistant providers in Oklahoma

Medicare billing

Part B allowed, 2024
$91,764
Medicare patients
344
Services billed
3,411

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide71$91,794
JardianceEmpagliflozin121$87,347
EliquisApixaban68$56,850
Trelegy ElliptaFluticasone/Umeclidin/Vilanter53$48,406
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog28$29,651
XareltoRivaroxaban17$16,815
MounjaroTirzepatide16$16,632
EntrestoSacubitril/Valsartan13$10,527
MyrbetriqMirabegron14$9,493
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$6,081
Novolog FlexpenInsulin Aspart12$2,942
BrilintaTicagrelor11$2,907
Albuterol Sulfate HfaAlbuterol Sulfate65$2,589
Omeprazole200$2,565
LantusInsulin Glargine,hum.Rec.Anlog17$2,545

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$37$91,79471 claims
Boehringer IngelheimJardiance$46$87,347121 claims
PfizerEliquis$21$56,85068 claims
GSKTrelegy Ellipta$14$48,40653 claims
Lilly USA, LLCMounjaro$28$16,63216 claims
NovartisEntresto$33$10,52713 claims
AbbVieArmour Thyroid$105$67119 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,491 physician assistant providers in Oklahoma.

Other physician assistant in Broken Bow

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →